Bibliography of Health Economics

Social security and Medicare present entirely different challenges, says this authority. But you would not know that to listen to Alan Greenspan’s comments last winter. He said both programs would have to be cut. In contrast, future social security obligations can be accommodated without serious changes, this noted economist argues. The growth of Medicare obligations is much faster and will indeed require serious attention. [2] Daron Acemoglu, David Cutler, Amy Finkelstein, and Joshua Linn. Did Medicare Induce Pharmaceutical Innovation? American Economic Review, 96(2):103–07, May 2006. The authors find no evidence that the introduction of Medicare in 1965 increased drug use by the elderly and no evidence that it stimulated development of new drugs for the elderly. [3] Daron Acemoglu and Amy Finkelstein. Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector. Working Paper 12254, National Bureau of Economic Research, Cambridge, Mass., 2006. Abstract: This paper examines the implications of regulatory change for the input mix and technology choices of regulated industries. We present a simple neoclassical framework that emphasizes the change in relative factor prices associated with the regulatory change from full cost to partial cost reimbursement, and investigate how this affects firms’ technology choices through substitution of (capital embodied) technologies for tasks previously performed by labor. We examine these implications empirically by studying the change from full cost to partial cost reimbursement under the Medicare Prospective Payment System (PPS) reform, which increased This paper examines the implications of regulatory change for the input mix and technology choices of regulated industries. We present a simple neoclassical framework that emphasizes the change in relative factor prices associated with the regulatory change from full cost to partial cost reimbursement, and investigate how this affects firms’ technology choices through substitution of (capital embodied) technologies for tasks previously performed by labor. We examine these implications empirically by studying the change from full cost to partial cost reimbursement under the Medicare Prospective Payment System (PPS) reform, which increased